Cooper Tire & Rubber Company (NYSE: CTB) today announced a quarterly dividend of 10.5 cents per share on common stock, payable June 26, 2020 to st
Cooper Tire & Rubber Company (NYSE: CTB) today reported a first quarter 2020 net loss of $12 million, or diluted loss per share of $0.23, compared
Evento promovido por centrais sindicais para celebrar o Dia do Trabalhador durou mais de seis horas e também contou com apresentações de artistas, como Roger Waters e Zélia Duncan.
Moderna Inc's (NASDAQ: MRNA) novel coronavirus vaccine program is brimming with activity, and the latest news out of the stable Friday is a 10-year strategic...
Final Results for the Year Ended 31 December 2019 LONDON, UK / ACCESSWIRE / April 30, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) ("Hemogenyx" or the "Company"), the biopharmaceutical ...
The Medicine Maker has published its Power List annually since 2015. For 2020, its sixth list was shortened from 100 to 60 entrants, with three top 20 lists celebrating the most influential leaders i
The acquisition included total stock and cash consideration of approximately $21 million, based on the value of the stock at closing. The first target for ranpirnase is human papillomavirus (HPV), th
China’s constantly shifting methodology for counting the number of cases of the coronavirus that causes COVID-19 has led it to greatly understate the numbers...
S&P Dow Jones Indices Launches Paris-Aligned Climate (PA), Climate Transition (ST) Eurozone Indices | STL.News
D.C. custom framing company Framebridge is now producing face shields at its manufacturing site in Kentucky.
Nanocap Orgenesis is acquiring Tamir Biotechnology's assets for $19 million. Teladoc shoots up with rise in interest in telemedicine amidst coronavirus. Plurist
Orgenesis plans to combine ranpirnase with its co-developed Bioxome™ technology for enhanced payload delivery directly to cells. TamirBio is a clinical stage anti-viral therapeutics company engaged
JV to utilize RevaTis’s patented technique to obtain mdMSCs through a minimally invasive muscle biopsy and leverage mdMSC manufacturing capability Plan to leverage Orgenesis’s.
Exosomes, or extracellular vesicles (EVs), are small vesicles that transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells. Exosomes are believed to provid
This past February, we completed the sale of Masthercell, which generated approximately $127 million in net proceeds to Orgenesis. This sale was an important step in our strategy to leverage our uniq
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE